Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Significance of Targeting VEGFR-2 and Cyclin D1 in Luminal-A Breast Cancer
Ashraf N. Abdalla, Amal Qattan, Waleed H. Malki, et al.
Molecules (2020) Vol. 25, Iss. 20, pp. 4606-4606
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Recent development of VEGFR small molecule inhibitors as anticancer agents: A patent review (2021–2023)
Jing Zeng, Qichuan Deng, Zheng Chen, et al.
Bioorganic Chemistry (2024) Vol. 146, pp. 107278-107278
Closed Access | Times Cited: 14
Degradation strategy of cyclin D1 in cancer cells and the potential clinical application
Shuyi Chen, Ling Li
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 22
Novel 4-(piperazin-1-yl)quinolin-2(1H)-one bearing thiazoles with antiproliferative activity through VEGFR-2-TK inhibition
Abdelfattah Hassan, Mohamed Badr, Heba A. Hassan, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 40, pp. 116168-116168
Closed Access | Times Cited: 30
Discovery of new pyrimidopyrrolizine/indolizine-based derivatives as P-glycoprotein inhibitors: Design, synthesis, cytotoxicity, and MDR reversal activities
Ahmed M. Shawky, Ashraf N. Abdalla, Nashwa A. Ibrahim, et al.
European Journal of Medicinal Chemistry (2021) Vol. 218, pp. 113403-113403
Closed Access | Times Cited: 29
Chemosensitization of HT29 and HT29-5FU Cell Lines by a Combination of a Multi-Tyrosine Kinase Inhibitor and 5FU Downregulates ABCC1 and Inhibits PIK3CA in Light of Their Importance in Saudi Colorectal Cancer
Ashraf N. Abdalla, Waleed H. Malki, Amal Qattan, et al.
Molecules (2021) Vol. 26, Iss. 2, pp. 334-334
Open Access | Times Cited: 24
Phytochemical, Cytotoxic, and Antimicrobial Evaluation of Tribulus terrestris L., Typha domingensis Pers., and Ricinus communis L.: Scientific Evidences for Folkloric Uses
Asaad Khalid, Alanood S. Algarni, Husham E. Homeida, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 17
A patent review of anticancer CDK2 inhibitors (2017–present)
Mohamed A. Said, Mohamed A. Abdelrahman, Mohammed A. S. Abourehab, et al.
Expert Opinion on Therapeutic Patents (2022) Vol. 32, Iss. 8, pp. 885-898
Closed Access | Times Cited: 15
In-vitro Cytotoxicity Investigations for Phytoconstituents of Saudi Medicinal Plants With Putative Ocular Effects
Ali Hendi Alghamdi, Aimun A. E. Ahmed, Haidar Abdalgadir, et al.
Integrative Cancer Therapies (2024) Vol. 23
Open Access | Times Cited: 2
Evaluation of the effects of a dasatinib-containing, self-emulsifying, drug delivery system on HT29 and SW420 human colorectal carcinoma cells, and MCF7 human breast adenocarcinoma cells
Rehab A Baghdadi, Ashraf N. Abdalla, Mohammed A. S. Abourehab, et al.
Journal of Taibah University Medical Sciences (2024) Vol. 19, Iss. 4, pp. 806-815
Open Access | Times Cited: 2
The active kinome: The modern view of how active protein kinase networks fit in biological research
Khaled Alganem, Abdul‐rizaq Hamoud, Justin F. Creeden, et al.
Current Opinion in Pharmacology (2021) Vol. 62, pp. 117-129
Open Access | Times Cited: 18
Bioactive fluorenes. Part IV: Design, synthesis, and a combined in vitro, in silico anticancer and antibacterial evaluation of new fluorene-heterocyclic sulfonamide conjugates
Essam M. Hussein, M. Shaheer Malik, Reem I. Alsantali, et al.
Journal of Molecular Structure (2021) Vol. 1246, pp. 131232-131232
Closed Access | Times Cited: 14
Pyrrolizine/indolizine-cinnamaldehyde Schiff bases: Design, synthesis, biological evaluation, ADME, and molecular docking study
Mohammed A. S. Abourehab, Alaa M. Alqahtani, Faisal A. Almalki, et al.
European Journal of Medicinal Chemistry Reports (2022) Vol. 4, pp. 100036-100036
Open Access | Times Cited: 10
Discovery and optimization of 2,3-diaryl-1,3-thiazolidin-4-one-based derivatives as potent and selective cytotoxic agents with anti-inflammatory activity
Ahmed M. Shawky, Faisal A. Almalki, Ashraf N. Abdalla, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115712-115712
Closed Access | Times Cited: 5
Bio-guided isolation and bioinformatic studies of cytotoxic phytosterols from Acanthospermum hispidum DC against breast (MCF7) and colorectal (HT29) cancer cells
Alshaimaa A. Alnoor, Ashraf N. Abdalla, Fatma M. Abdel Bar, et al.
Arab Journal of Basic and Applied Sciences (2024) Vol. 31, Iss. 1, pp. 358-370
Open Access | Times Cited: 1
Therapeutic Potential of Acanthospermum hispidum: A Comprehensive Analysis of Its Antimicrobial, Antioxidant, and Anticancer Properties
Ehssan Moglad, Alshaimaa A. Alnoor, Nagla Mustafa Eltayeb, et al.
Journal of Spectroscopy (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 1
The Anticancer Properties, Cell-cycle Cytotoxicity and Apoptosis of Cissus rotundifolia, Trema orientalis, and Buddleja polystachya with Ocular Applications
Ali Hendi Alghamdi, Aimun A. E. Ahmed, Mahadi Bashir, et al.
Phytomedicine Plus (2024), pp. 100651-100651
Open Access | Times Cited: 1
Co-Inhibition of P-gp and Hsp90 by an Isatin-Derived Compound Contributes to the Increase of the Chemosensitivity of MCF7/ADR-Resistant Cells to Doxorubicin
Ashraf N. Abdalla, Miriana Di Stefano, Giulio Poli, et al.
Molecules (2021) Vol. 27, Iss. 1, pp. 90-90
Open Access | Times Cited: 12
Phenolic contents, anticancer, antioxidant, and antimicrobial capacities of MeOH extract from the aerial parts of Trema orientalis plant
Sami Asir Al‐Robai, Sami A. Zabin, Abdelazim A. Ahmed, et al.
Open Chemistry (2022) Vol. 20, Iss. 1, pp. 666-678
Open Access | Times Cited: 7
In Silico Approach Using Free Software to Optimize the Antiproliferative Activity and Predict the Potential Mechanism of Action of Pyrrolizine-Based Schiff Bases
Faisal A. Almalki, Ashraf N. Abdalla, Ahmed M. Shawky, et al.
Molecules (2021) Vol. 26, Iss. 13, pp. 4002-4002
Open Access | Times Cited: 10
Evaluating dasatinib nanocarrier: Physicochemical properties and cytotoxicity activity on cancer cells.
Jamila Ahmad Altoham, Ashraf N. Abdalla, Mohammed A. S. Abourehab, et al.
PubMed (2024) Vol. 18, Iss. 4, pp. 14-21
Closed Access
Microwave-assisted synthesis, characterization, and molecular docking studies of new chlorophthalazine derivatives as anticancer activity
Samar A. Abubshait, Rasha Almalih, Haya A. Abubshait, et al.
Arab Journal of Basic and Applied Sciences (2024) Vol. 31, Iss. 1, pp. 454-469
Open Access
Receptor tyrosine kinases in breast cancer treatment: unraveling the potential
Qi Yu, Shumin Deng, Kuan-Song Wang
American Journal of Cancer Research (2024) Vol. 14, Iss. 9, pp. 4172-4196
Closed Access
Cytotoxic activity, selectivity, and clonogenicity of fruits and resins of Saudi medicinal plants against human liver adenocarcinoma
Ali Hendi Alghamdi, Aimun A. E. Ahmed, Mahadi Bashir, et al.
Drug Target Insights (2024) Vol. 18, Iss. 1, pp. 84-93
Open Access
Ganoderma lucidum (Curtis) P. Karst. Immunomodulatory Protein Has the Potential to Improve the Prognosis of Breast Cancer Through the Regulation of Key Prognosis-Related Genes
Zanwen Zuo, Ran Wen, Shuang Jing, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1695-1695
Open Access
Inhibitory Effect of Lentivirus-Mediated Gag-Caspase-8 on the Growth of HER-2 Overexpressing Primary Human Breast Cancer Cells
Min Wang, Xiping Li, Wei Xie, et al.
Cancer Biotherapy and Radiopharmaceuticals (2021) Vol. 37, Iss. 8, pp. 720-728
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top